| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/17/2003 | US20030134350 Zinc finger domain recognition code and uses thereof |
| 07/17/2003 | US20030134315 Testing a sample from a cancer patient for the expression of a negative signal transduction factor (NSTF) and for the expression of a positive signal transduction factor (PSTF), selecting chemotherapeutic agent for treatment based on above |
| 07/17/2003 | US20030134306 Human and murine cytokine polypeptides |
| 07/17/2003 | US20030134284 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134263 Controlling gene expression; transfection of cell |
| 07/17/2003 | US20030133931 Combining a putative modulator compound of mammalian histamine H4 receptor protein activity with mammalian histamine H4 receptor protein and a known histamine receptor H4 ligand, measuring the effect of the modulator on the protein |
| 07/17/2003 | US20030133924 Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease |
| 07/17/2003 | US20030131532 Floral packaging material having great masters prints thereon |
| 07/17/2003 | CA2514872A1 Purification and characterization of hla proteins |
| 07/17/2003 | CA2472937A1 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| 07/17/2003 | CA2472826A1 Antibodies directed to pdgfd and uses thereof |
| 07/17/2003 | CA2472383A1 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 07/17/2003 | CA2472180A1 Hair follicle growth |
| 07/17/2003 | CA2472111A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | CA2472049A1 Dominant negative proteins and methods thereof |
| 07/17/2003 | CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | CA2471849A1 Antibodies against the muc18 antigen |
| 07/17/2003 | CA2471551A1 Methods to engineer mammalian-type carbohydrate structures |
| 07/17/2003 | CA2471431A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/17/2003 | CA2471214A1 The use of histamine h4 receptor antagonist for the treatment of inflammatory response |
| 07/17/2003 | CA2471178A1 Recombinant protein expression |
| 07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | CA2468888A1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 07/17/2003 | CA2467084A1 Mutant chromophores/fluorophores and methods for making and using the same |
| 07/17/2003 | CA2467083A1 Viral capsid assembly intermediates |
| 07/16/2003 | EP1327685A1 Bzip transcripiton factors that controls expression of the storage protein in the rice plant |
| 07/16/2003 | EP1326995A2 Method for synthesising peptides, peptide mimetics and proteins |
| 07/16/2003 | EP1326989A1 EXPRESSION VECTORS WITH MODIFIED ColE1 ORIGIN OF REPLICATION FOR CONTROL OF PLASMID COPY NUMBER |
| 07/16/2003 | EP1326983A2 Gene cluster for ramoplanin biosynthesis |
| 07/16/2003 | EP1326978A2 Hematopoietin receptors hpr1 and hpr2 |
| 07/16/2003 | EP1326976A1 Mfq-114, a human ajuba like protein |
| 07/16/2003 | EP1326972A2 Transporters and ion channels |
| 07/16/2003 | EP1326971A2 Proteins and nucleic acids encoding same |
| 07/16/2003 | EP1326970A2 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
| 07/16/2003 | EP1326896A2 Human anti-cd40 antibodies |
| 07/16/2003 | EP1326895A1 Monoclonal antibodies directed against hepatitis b viruses |
| 07/16/2003 | EP1326894A2 Novel tumor-associated marker |
| 07/16/2003 | EP1326891A1 Gene encoding a human g-protein coupled receptor and its use |
| 07/16/2003 | EP1326882A2 Enterokinase cleavage sequences and their use |
| 07/16/2003 | EP1326880A1 Method for the selective modification of peptides and proteins |
| 07/16/2003 | EP1326628A2 Chemokine mutants in the treatment of multiple sclerosis |
| 07/16/2003 | EP1075513A4 Continuous in vitro evolution |
| 07/16/2003 | EP1025231B1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance |
| 07/16/2003 | EP1019510B1 Vaccines derived from porcine circoviruses |
| 07/16/2003 | EP0852586B1 Use of a 24 kDa protein for treating and diagnosing an HCV Infektion |
| 07/16/2003 | EP0801658B1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/16/2003 | EP0789767B1 A method for producing purified papillomavirus proteins |
| 07/16/2003 | EP0759935B1 Recombinant papilloma virus l1 |
| 07/16/2003 | EP0743856B1 Antigen-based heteropolymers for treating autoimmune diseases |
| 07/16/2003 | CN1430674A Production of silk-like proteins in plants |
| 07/16/2003 | CN1430626A Sheep lice Bobicola ovis allergen treatment |
| 07/16/2003 | CN1429908A Gene modification sequence of gene recombination hepatitis virus surface antigen and its product |
| 07/16/2003 | CN1429905A Recombination adenopathy adjoint virus carrier capable of controlling digene expression for treating parkinsonism |
| 07/16/2003 | CN1429846A Tumour nascent blood ressel specificity conjugated polypeptide and human alpha interferon fusion protein and preparation |
| 07/16/2003 | CN1429841A New human protein having mouse NIH/3T3 cell conversion promoting function and its code sequence |
| 07/16/2003 | CN1429840A New human protein having cancer cell growth in hibiting function and its code sequence |
| 07/16/2003 | CN1429839A New human protein having cancer inhibiting function and its code sequence |
| 07/16/2003 | CN1114619C Preparation method of liver cancer murine monoclone antibody of mouse hybridoma strain Hepama-1 secretory |
| 07/16/2003 | CN1114616C Exciter for inducing allergic reaction of plant and preparation method and use thereof |
| 07/15/2003 | US6593461 Isolated DNA of given nucleotide sequence which encodes an amino acid sequence; hybridization; use in diagnosing, preventing and treating gastrointestinal disorders |
| 07/15/2003 | US6593297 Compounds and methods for inhibiting cancer metastasis |
| 07/15/2003 | US6593140 Animal cell culture |
| 07/15/2003 | US6593137 Antibodies specific for fullerenes |
| 07/15/2003 | US6593135 Quantitative analysis |
| 07/15/2003 | US6593133 Neurotrophic factors |
| 07/15/2003 | US6593109 Culturing cells containing DNA sequences under the control of a regulatory sequence capable of directing expression; useful in treating bone defects, healing bone injury and wounds |
| 07/15/2003 | US6593108 Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide |
| 07/15/2003 | US6593107 Methods of refolding proteins |
| 07/15/2003 | US6593106 Methods of refolding proteins |
| 07/15/2003 | US6593105 Vector comprising a nucleic acid insert; alteration of amino acids within the helix-1 region; inability to convert to a disease-associated form; use in prophylaxis/gene therapy for neurodegenerative diseases |
| 07/15/2003 | US6593103 HIV capsid assembly-associated compositions and method |
| 07/15/2003 | US6593082 DNA oligonucleotide comprising the viral polymerase promoter; amplification; transcribing and translating the products in eukaryotic cell-free lysates in presence of a radio-labelled agent; measuring the priming activity |
| 07/15/2003 | US6593081 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 07/15/2003 | US6593079 Method for simultaneous detection of HIV antigens and HIV antibodies |
| 07/15/2003 | US6592873 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | CA2058820C Expression cassettes and vectors for the secretion of human serum albumin in pichia pastoris cells |
| 07/10/2003 | WO2003056332A1 Diagnostic for scleroderma |
| 07/10/2003 | WO2003056020A2 Expression vectors and promoters for heterologous gene expression |
| 07/10/2003 | WO2003056018A1 Pyroglutamyl peptidase and its gene |
| 07/10/2003 | WO2003056016A1 Fungus-origin lysyl oxidases |
| 07/10/2003 | WO2003056009A1 Nucleotide sequences having activity of controlling translation efficiency and utilization thereof |
| 07/10/2003 | WO2003055994A1 Hxhv virus, nucleic material, peptide material and uses |
| 07/10/2003 | WO2003055980A2 Il-17 like molecules and uses thereof |
| 07/10/2003 | WO2003055975A2 A method for engineering strand-specific, sequence-specific, dna-nicking enzymes |
| 07/10/2003 | WO2003055917A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 07/10/2003 | WO2003055916A2 Adiponectin fragments and conjugates |
| 07/10/2003 | WO2003055913A2 Secreted protein |
| 07/10/2003 | WO2003055912A2 Secreted proteins |
| 07/10/2003 | WO2003055911A2 Cystine-knot fold protein |
| 07/10/2003 | WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof |
| 07/10/2003 | WO2003055515A1 Individualized anti-cancer antibodies |
| 07/10/2003 | WO2003055440A2 Compositions and methods for the treatement of immune related diseases |
| 07/10/2003 | WO2003033677A3 Dimerized growth factor and materials and methods for producing it |
| 07/10/2003 | WO2003033580A3 Non-degradable and degradable porous materials with high surface areas |
| 07/10/2003 | WO2003024992A3 HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES |
| 07/10/2003 | WO2003023030A3 Aminopeptidase |
| 07/10/2003 | WO2003008452A3 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
| 07/10/2003 | WO2003008376A3 Adhesive dopa-containing polymers and related methods of use |
| 07/10/2003 | WO2003007880A3 Inhibition of behab cleavage and primary central nervous system (cns) tumors |